1. Home
  2. Bills
  3. S. 139

S. 139 · 114th Congress · 2015–2016

Ensuring Access to Clinical Trials Act of 2015

S. 139 in the 114th Congress (2015–2016) became law — introduced on Jan 8, 2015, sponsored by Ron Wyden with 15 co-sponsors.

During the 114th Congress (2015–2016), Barack Obama was president, and Republicans held majorities in both the House and Senate.

Status
Became law
Introduced
Jan 8, 2015
Co-sponsors
15
Policy area
Health
Public law
Public Law 114-63

What it does

This measure has not been amended since it was introduced. The expanded summary of the Senate-passed version is repeated here.) Ensuring Access to Clinical Trials Act of 2015 (Sec. 2) This bill amends the Improving Access to Clinical Trials Act of 2009 to repeal the sunset of, and so extend indefinitely, the exclusion from resources under titles XVI (Supplemental Security Income) and XIX (Medicaid) of the Social Security Act,…

Summary by the nonpartisan Congressional Research Service.

Sponsor

Ron Wyden (D-OR). Co-sponsors: 10 Democrats, 5 Republicans.

Where it stands

  • IntroducedJan 8, 2015
  • Passed the SenateJul 16, 2015
  • Passed the HouseSep 28, 2015
  • Sent to the PresidentSep 30, 2015
  • Became lawOct 7, 2015

Latest action: Became Public Law No: 114-63. (Oct 7, 2015)

More bills from Ron Wyden in the 114th Congress

Other Health bills in the 114th Congress

Committees

More

From GovInfo bill records, Congressional Research Service summaries, Voteview roll calls and lobbying reports.

Cite or embed this page

Capitol Receipts, “S. 139 (114th Congress): Ensuring Access to Clinical Trials Act of…,” https://www.capitolreceipts.com/bill/114-s-139/ensuring-access-to-clinical-trials-act-of-2015 (accessed 2026-10-17).